Abnormal eosinophils, eosinophilia and basophilia in methimazole neutropenia.
D000380:Agranulocytosis / Q000139:chemically induced* / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000936:Antigen-Antibody Complex; D013956:Antithyroid Agents / Q000009:adverse effects*; D001491:Basophils / Q000187:drug effects; D003593:Cytoplasm; D003594:Cytoplasmic Granules; D003875:Drug Eruptions / Q000209:etiology*; D004802:Eosinophilia / Q000139:chemically induced* / Q000276:immunology; D004804:Eosinophils / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000188:drug therapy; D007093:Imidazoles / Q000009:adverse effects*; D007118:Immunoassay; D007565:Jaundice / Q000150:complications; D007958:Leukocyte Count; D008713:Methimazole / Q000009:adverse effects; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects
D000906:Antibodies; D000936:Antigen-Antibody Complex; D013956:Antithyroid Agents; D007093:Imidazoles; D008713:Methimazole